MedPath
NMPA Approval

Fulvestrant Injection

国药准字H20243158

February 6, 2024

Drug Information

氟维司群注射液

注射剂

5ml:0.25g

化学药品

February 6, 2024

Company Information

Applicant Company

河北省石家庄市高新区太行大街769号京津冀协作创新示范园203C507

Manufacturing Company

福建省莆田市秀屿区笏石镇丙仑村仁洋288号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氟维司群注射液 - NMPA 批准文号 | MedPath